FDAMA 114 and the 21st Century Cures Act
By Xcenda |
Xcenda presented an educational symposium on FDAMA 114 and the 21st Century Cures Act at ISPOR's 22nd International Meeting in Boston on May 23, 2017. Jay Jackson, PharmD, MPH, moderated a panel of experts to discuss insights from US payers and pharmaceutical manufacturers on the implications of the 21st Century Cures Act on the exchange of HCEI.
